Drug maker will pay for competing ED drug

Lilly ICOS has launched a limited-time offer called "The Cialis Challenge," which offers to pay for a competing erectile dysfunction drug if a patient is not satisfied with tadalafil (Cialis).

Related Content:

Drug Therapy

Pivotal data for lumasiran in PH1 published in NEJM

Nedosiran explored in primary hyperoxaluria type 3

Enrollment completed in pivotal trial of nedosiran for hyperoxaluria